Nevertheless, a recent study revealed astrocytic loss in a subset of early MS lesions as well as the repopulation of active lesions with AQP4-negative/GFAP-positive astrocytic precursors, similar to those detectable in our CPM lesions and in non-necrotic NMO lesions [74]. The gene discussed is GFAP; the disease is myeloid sarcoma.